Track topics on Twitter Track topics that are important to you
Bio-IT World | This summer, Foundation Medicine will launch what could be described as the next generation of cancer diagnostics. The Cambridge, Mass.-based company, founded by a premier group of can...
Quest Diagnostics has introduced three new cancer test services, which will enable clinicians to predict the development of hereditary forms of cancer in individuals.
Louisville startup Breath Diagnostics has developed technology to pick up cancer-related compounds that are exhaled in one’s breath.
AccuraGen Holdings, a US-China cancer diagnostics company, has closed a $40 million Series B financing. AccuraGen develops blood tests that sequence cell free DNA (cfDNA) to provide sensitive and accu...
Recent advances have made diagnostic drug sensitivity testing for cancer a reality. What methods are currently available for drug sensitivity testing in gastric cancer diagnostics? Journal of Clinic...
Aberdeen, we say goodbye to you! We’re leaving Scotland this week and are heading down to Belgium. Besides being the place where most of the European Union action happens, Belgium also has a st...
What about PDL-1 in oncotherapy diagnostics for NSCLC? Larry H. Bernstein, MD, FCAP, Curator LPBI Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC Alexander M. Castellino, PhD http://w...
Quest Diagnostics has agreed to make available Biocept's Target Selector mutation detection test for lung cancer in Mexico fo -More-
Single-cell proteomics in cancer is evolving and promises to provide more accurate diagnoses based on detailed molecular features of cells within tumors. This review focuses on technologies that allow...
Gastric cancer diagnostics has traditionally been histomorphological and primarily the domain of surgical pathologists. Although there is an increasing usage of molecular and genomic techniques for cl...
Companion diagnostics (CDx) have become a major tool in molecular pathology and assist in therapy decisions in an increasing number of various cancers. Particularly, the developments in lung cancer ha...
Gastric cancer is the fourth most common type of cancer and represents a major cause of cancer-related deaths worldwide. With recent biomedical advances in our understanding of the molecular character...
Early diagnostics of colorectal cancer is complicated by the lack of reliable serum biomarkers. This study aimed to investigate if the serum level of activin A can be used for diagnostics of this dise...